A Phase 1 clinical trial is evaluating an investigational vaccine designed to protect against coronavirus disease in Seattle.
The open-label trial will enroll 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks. The first participant received the investigational vaccineon Monday, March 16th.
The study is evaluating different doses of the experimental vaccine for safety, and its ability to induce an immune response in participants. This is the first of multiple steps in the clinical trial process for evaluating the potential benefit of the vaccine.
The investigational vaccine was developed using a genetic platform called mRNA. The investigational vaccine directs the body’s cells to express a virus protein that it is hoped will elicit a robust immune response.
The mRNA-1273 vaccine has shown promising results in animal models, and this is the first tiem it will be used on humans.
The Yucatan Times
Newsroom
Comments
more recommended stories
-
AMLO’s Banco del Bienestar to be controlled by Mexican Army
The decision makes sense if one.
Why it doesn’t matter that so many die in Mexico from Covid-19There are so many deaths that.
Having a hard time getting a turkey for Thanksgiving?It is almost impossible to find.
Great-grandson of María Sabina struggles to rescue her remainsMaría Sabina Magdalena García was a.
San Antonio, TX could be hosting Canelo vs SmithIf you’re a boxing fan, you’re.
Randy Arozarena: from the World Series to Mérida’s CERESO in less than a monthInterviewed at her home in the.
Donald Trump pardoned his former security advisor Michael Flynn.“I know you will now have.
Mayan communities of Campeche deliver 268 thousand signatures against the Mayan Train.The protesters stated that the Mayan.
Cenote divers in Tulum must be regulated by Civil ProtectionTulum, Q.R. — The Directorate of.
86 percent progress reported in the Mérida – Chetumal highway repaving worksMérida, Yucatán (November 25, 2020).- The.
BUSQUE A UN MÉDICO
Leave a Comment